Canada markets closed

Biora Therapeutics, Inc. (BIOR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.7310+0.0182 (+2.55%)
At close: 04:00PM EDT
0.7489 +0.02 (+2.45%)
After hours: 05:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 25.58M
Enterprise Value 57.79M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.81k
Price/Book (mrq)N/A
Enterprise Value/Revenue 14.45k
Enterprise Value/EBITDA -0.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-72.26%
S&P500 52-Week Change 322.43%
52 Week High 36.7000
52 Week Low 30.5850
50-Day Moving Average 30.9301
200-Day Moving Average 31.7127

Share Statistics

Avg Vol (3 month) 3453.23k
Avg Vol (10 day) 3221.65k
Shares Outstanding 535.88M
Implied Shares Outstanding 635.88M
Float 813.75M
% Held by Insiders 10.82%
% Held by Institutions 161.29%
Shares Short (Apr 15, 2024) 41.4M
Short Ratio (Apr 15, 2024) 42.39
Short % of Float (Apr 15, 2024) 48.62%
Short % of Shares Outstanding (Apr 15, 2024) 43.90%
Shares Short (prior month Mar 15, 2024) 41.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Jan 03, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,678,575.00%

Management Effectiveness

Return on Assets (ttm)-99.04%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -66.59M
Net Income Avi to Common (ttm)-124.33M
Diluted EPS (ttm)-7.8800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.21M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)47.83M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.30
Book Value Per Share (mrq)-3.64

Cash Flow Statement

Operating Cash Flow (ttm)-48.5M
Levered Free Cash Flow (ttm)11.93M